A Specific Inflammatory Profile Underlying Suicide Risk? Systematic Review of the Main Literature Findings.
immune pathways
immunological differences
inflammatory cytokines
major depressive disorder
suicidal behavior
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
01 04 2020
01 04 2020
Historique:
received:
13
02
2020
revised:
09
03
2020
accepted:
26
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
22
10
2020
Statut:
epublish
Résumé
Consistent evidence indicates the association between inflammatory markers and suicidal behavior. The burden related to immunological differences have been widely documented in both major affective disorders and suicidal behavior. Importantly, abnormally elevated pro-inflammatory cytokines levels have been reported to correlate with suicidal behavior but whether and to what extent specific inflammatory cytokines abnormalities may contribute to our understanding of the complex pathophysiology of suicide is unknown. The present manuscript aimed to systematically review the current literature about the role of pro-inflammatory cytokines in suicidal behavior. Most studies showed a link between abnormally higher interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β1, vascular endothelial growth factor (VEGF), kynurenic acid (KYN), and lower IL-2, IL-4, and interferon (IFN)-γ levels in specific brain regions and suicidal behavior. Unfortunately, most studies are not able to exclude the exact contribution of major depressive disorder (MDD) as a mediator/moderator of the link between inflammatory cytokines abnormalities and suicidal behavior. The association between suicidal patients (both suicide attempters or those with suicidal ideation) and the altered immune system was documented by most studies, but this does not reflect the existence of a specific causal link. Additional studies are needed to clarify the immune pathways underlying suicidal behavior.
Identifiants
pubmed: 32244611
pii: ijerph17072393
doi: 10.3390/ijerph17072393
pmc: PMC7177217
pii:
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
Psychol Med. 2009 Mar;39(3):413-23
pubmed: 18533059
Psychiatry Res. 2019 Mar;273:685-689
pubmed: 31207853
Bipolar Disord. 2006 Oct;8(5 Pt 2):551-7
pubmed: 17042828
Transl Psychiatry. 2012 Nov 20;2:e196
pubmed: 23168996
Biol Psychiatry. 2009 Aug 1;66(3):287-92
pubmed: 19268915
Psychosom Med. 1998 Jul-Aug;60(4):484-91
pubmed: 9710295
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):356-61
pubmed: 17919797
Pharmacol Rev. 2013 Dec 11;66(1):80-101
pubmed: 24335193
J Child Adolesc Psychopharmacol. 2009 Aug;19(4):423-30
pubmed: 19702494
Transl Psychiatry. 2016 Nov 8;6(11):e946
pubmed: 27824355
Psychoneuroendocrinology. 2013 Jun;38(6):853-62
pubmed: 23062672
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Brain Behav Immun. 2015 Oct;49:206-15
pubmed: 26065825
Neuropsychopharmacology. 2017 Jan;42(1):242-253
pubmed: 27480575
Biol Psychiatry. 2018 Jan 1;83(1):61-69
pubmed: 28939116
J Affect Disord. 2013 Sep 25;150(3):923-30
pubmed: 23856278
Brain Behav Immun. 2011 Aug;25(6):1272-8
pubmed: 21605657
JAMA Psychiatry. 2013 Feb;70(2):176-84
pubmed: 23266538
Lancet Psychiatry. 2017 Jul;4(7):563-572
pubmed: 28454915
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:102-11
pubmed: 24104186
J Psychiatr Res. 2018 Nov;106:38-42
pubmed: 30261413
Brain Behav Immun. 2015 Jan;43:110-7
pubmed: 25124710
J Clin Psychiatry. 2014 Nov;75(11):1242-53
pubmed: 25470085
Acta Psychiatr Scand. 2015 Sep;132(3):192-203
pubmed: 26256862
Biol Psychiatry. 2015 Jul 1;78(1):28-37
pubmed: 25541493
Dialogues Clin Neurosci. 2009;11(3):319-32
pubmed: 19877499
Int Immunopharmacol. 2006 Aug;6(8):1298-304
pubmed: 16782542
J Clin Psychiatry. 2005 Jan;66(1):41-8
pubmed: 15669887
Psychoneuroendocrinology. 2011 Apr;36(3):426-36
pubmed: 21041030
Psychoneuroendocrinology. 2019 Jan;99:236-242
pubmed: 30326381
Psychiatry Res. 2012 Dec 30;200(2-3):389-94
pubmed: 22748186
Psychoneuroendocrinology. 2017 Mar;77:284-294
pubmed: 28135675
Eur Neuropsychopharmacol. 2013 Dec;23(12):1672-86
pubmed: 23896009
World J Biol Psychiatry. 2012 Sep;13(6):468-73
pubmed: 22098148
Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):11-38
pubmed: 7708925
Brain Behav Immun. 2015 Oct;49:130-9
pubmed: 26044086
Clin Neuropharmacol. 2010 Nov-Dec;33(6):312-6
pubmed: 21079457
CNS Neurol Disord Drug Targets. 2017;16(4):440-453
pubmed: 28412922
Lancet. 2016 Aug 27;388(10047):881-90
pubmed: 27289172
Lancet Psychiatry. 2015 Mar;2(3):258-270
pubmed: 26359903
J Psychiatry Neurosci. 2018 Nov 01;43(6):376-385
pubmed: 30371993
Psychoneuroendocrinology. 2013 Jan;38(1):107-14
pubmed: 22683211
Brain Behav Immun. 2019 Aug;80:292-299
pubmed: 30953777
Nat Rev Immunol. 2016 Jan;16(1):22-34
pubmed: 26711676
J Psychiatr Res. 2018 Jul;102:150-158
pubmed: 29660602
Braz J Psychiatry. 2012 Mar;34(1):71-5
pubmed: 22392392
Psychoneuroendocrinology. 2013 Nov;38(11):2628-39
pubmed: 23845513
Ann N Y Acad Sci. 2018 Sep;1428(1):5-13
pubmed: 29806109
Sci Rep. 2017 Dec;7(1):89
pubmed: 28273888
J Clin Pathol. 2010 Nov;63(11):967-71
pubmed: 20924087
J Affect Disord. 2017 Apr 01;212:78-85
pubmed: 28157550
Immunol Lett. 1999 Apr 1;67(2):105-8
pubmed: 10232390
World J Biol Psychiatry. 2016 Dec;17(8):564-586
pubmed: 26223957
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:1-6
pubmed: 23200828
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):664-75
pubmed: 20599581
J Affect Disord. 2013 Sep 5;150(2):668-72
pubmed: 23608119
Indian J Psychiatry. 2013 Jul;55(3):256-63
pubmed: 24082246
Am J Psychiatry. 2018 Mar 1;175(3):262-274
pubmed: 29361849
Brain Behav Immun. 2014 Nov;42:50-9
pubmed: 24858659
Int J Environ Res Public Health. 2018 Jul 06;15(7):
pubmed: 29986446
Acta Psychiatr Scand. 2008 Mar;117(3):198-206
pubmed: 18081924
Mol Psychiatry. 2011 Jul;16(7):751-62
pubmed: 20479761
Sci Rep. 2013;3:2027
pubmed: 24002359
J Psychiatr Res. 2012 Jan;46(1):57-63
pubmed: 21906753
Brain Behav Immun. 2019 Oct;81:24-40
pubmed: 31195092
Brain Behav Immun. 2015 May;46:203-11
pubmed: 25678163
Adv Exp Med Biol. 1999;461:25-46
pubmed: 10442165
Acta Psychiatr Scand. 1993 Jul;88(1):48-52
pubmed: 8372695
Brain Behav Immun. 2011 Feb;25(2):335-9
pubmed: 20951793
Depress Anxiety. 2013 Apr;30(4):307-14
pubmed: 23504697
J Affect Disord. 2019 Mar 15;247:57-65
pubmed: 30654266
Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):50-62
pubmed: 29358037